Inside Oxford's innovation and spin-out cluster
How Oxford turns research into companies: the University’s technology transfer office, a patient-capital investor, the science parks, and the companies that prove the model.
Photo: Des Blenkinsopp, CC BY-SA 2.0, via Wikimedia Commons
Oxford’s reputation for turning research into companies rests on a few concrete pieces: an office that patents and licenses the University’s discoveries, an investor built to back them for the long term, science parks where they can grow, and a run of companies that have shown the model works. This guide explains each one.
At a glance
| Piece | What it is | Since |
|---|---|---|
| Oxford University Innovation | The University’s technology transfer company | 1987, as Isis Innovation from 1988 |
| Oxford Science Enterprises | Investor in Oxford spin-outs, with the University as a shareholder | 2015 |
| Oxford Science Park | 70-acre science park in Littlemore, owned by Magdalen College | 1991 |
| Harwell Campus | National science campus south of Oxford, home of Diamond Light Source | - |
How a spin-out is made
Oxford University Innovation manages the commercialisation of the University’s research: patents, licences and the formation of spin-out companies. It started in 1987, traded as Isis Innovation from 1988 and took its present name in 2016. According to the World Intellectual Property Organization, it is the largest university filer of international patent applications in the UK.
Oxford Science Enterprises, founded in 2015, invests in those spin-outs. Its first fundraising brought in £600 million, from backers including Google Ventures and Lansdowne Partners. The University is a shareholder, and the firm describes itself as patient capital: it has no fixed fund life, so it can stay with a company for longer than a normal venture fund.
The companies that prove it
- Oxford Nanopore Technologies was spun out of the University in 2005, founded by Hagan Bayley with Gordon Sanghera and Spike Willcocks. It makes nanopore devices that read DNA and RNA in real time, including the MinION, a sequencer the size of a harmonica, and it listed on the London Stock Exchange on 30 September 2021. Its headquarters are at the Oxford Science Park.
- The Oxford-AstraZeneca vaccine was developed by the University’s Jenner Institute with AstraZeneca. The UK approved it on 30 December 2020, the first country to do so, and more than 3 billion doses were supplied worldwide.
- Oxford Ionics, a quantum computing spin-out from the Department of Physics founded in 2019, was bought by IonQ in 2025 for $1.075 billion, the University’s highest-value quantum spin-out acquisition. Read the full story.
Where they grow
The Oxford Science Park in Littlemore, about 5 kilometres south of the centre, opened in 1991. It covers 70 acres, is owned by Magdalen College, and employs around 3,000 people; in 2025 part of it was sold to the Ellison Institute of Technology.
Further south, the Harwell Campus near Didcot is home to national facilities including Diamond Light Source, the UK’s national synchrotron science facility.
The constraints
The model’s limits are well known in the city: laboratory space is scarce, housing is expensive, and companies that grow quickly often find it hard to stay. For events where the science meets the public, see our page on Anna Dumitriu’s BioArt exhibition at the John Radcliffe Hospital.
Frequently asked questions
What is Oxford University Innovation?
The University of Oxford’s technology transfer company. It handles patents and licences and helps researchers form spin-out companies.
Who invests in Oxford spin-outs?
Among others, Oxford Science Enterprises, founded in 2015, in which the University is a shareholder. It raised £600 million in its first round.
Which are the best-known Oxford spin-outs?
Oxford Nanopore Technologies, founded in 2005 and listed in 2021, and Oxford Ionics, bought by IonQ in 2025 for $1.075 billion. The Oxford-AstraZeneca COVID-19 vaccine also came out of the University’s Jenner Institute.
Sources
- en.wikipedia.org, Oxford University Innovation
- en.wikipedia.org, Oxford Science Enterprises
- en.wikipedia.org, Oxford Nanopore Technologies
- en.wikipedia.org, Oxford-AstraZeneca COVID-19 vaccine
- physics.ox.ac.uk, Oxford Ionics acquisition
- en.wikipedia.org, Oxford Science Park
- en.wikipedia.org, Diamond Light Source
This article was written by the Oxford Society editorial desk from the public sources listed above. We are not affiliated with the people, companies or institutions it describes.
← Back to Guides